China-WHO country cooperation strategy 2022–2026

Overview

The World Health Organization (WHO) country cooperation strategy (CCS) is a strategic framework to guide the Organization’s work in and with a given Member State. It includes an analysis of the country’s health situation, a review of the current collaboration between the country and WHO, and an overview of strategic objectives for future cooperation. It reflects the country’s national health and development agenda and identifies a set of agreed joint priorities for WHO collaboration.

In 2021, WHO and the National Health Commission (NHC) jointly reviewed the implementation of the China-WHO Country Cooperation Strategy 2016–2020 as the foundation to prepare for a new CCS for cooperation between 2022 and 2026. In the coming years, cooperation between China and WHO will have a vital influence on the health and well-being of 1.4 billion Chinese people and beyond.

The China-WHO Country Cooperation Strategy 2022–2026 has two distinctive and interlinked dimensions – domestic and global – that reflect where China stands in its national development and global roles. These dimensions are used in this document as the basis for analysing the context, presenting achievements and challenges, and defining future priorities. Domestically, China has embarked on an ambitious national development journey. Globally, China is committed to the international development agendas set forth by the United Nations and WHO.